The Softer Side of Drugs

Key Points

• Research suggests kratom’s illicit market has less stigma, with federal efforts to ban it largely backed down, unlike cannabis.

• It seems likely that pain and addiction are key issues, given kratom’s narrow medicinal molecules compared to cannabis’s broader endocannabinoid system.

• The evidence leans toward corruption in importing, processing, and sales, with smuggling and mislabeling cases highlighting criminal activities.

Importing the Leaf

Kratom is mainly imported from Southeast Asia, like Indonesia, where farmers harvest it, but the FDA’s strict rules, including detention without physical examination, make legal imports tough. Smuggling and mislabeling, like declaring it as fertilizer, are common, with cases like Sebastian Guthery’s showing how importers try to bypass these rules.

Processing & Purification

Once in the US, kratom is processed into powders, capsules, or extracts, often with inconsistent quality. Contaminated products, like those with Salmonella, pose health risks, and the lack of regulation means some operations cut corners, potentially fueling criminal activities.

Products & Sales

Kratom is sold online, at gas stations, and smoke shops, often with exaggerated health claims. The billion-dollar industry lacks oversight, allowing bad actors to market unsafe products, which can lead to addiction and overdoses, as seen in Florida cases linked to brands like O.P.M.S.

Enforcement & Policy

The FDA warns against kratom use, but federal regulation is weak, with states varying from bans to consumer protection acts. This patchwork creates loopholes for illegal sales, and the DEA’s light touch compared to cannabis suggests less stigma, possibly due to lobbying.

Big Pharma's Competitive Opioids

Kratom competes with big pharma’s opioids for pain and addiction treatment, threatening their market. This likely fuels lobbying to restrict kratom, with big pharma’s influence potentially corrupting policy, as seen in the FDA’s aggressive stance despite limited evidence.

Corruption, Criminal Activities, & Dark Money

Corruption overlays kratom’s trade, from bribes to get shipments through customs to money laundering, as in Guthery’s case. The lack of oversight in importing and sales creates opportunities for criminal networks, exploiting regulatory gaps for profit.

Pertinent Information

This note provides a comprehensive evaluation of the most pertinent information for the "State of Kratom" project by State of X Studios (SXS), focusing on flushing out the hype, bullshit, and criminal activities in the world of kratom. The analysis covers importing the leaf, processing and purification, products and sales, enforcement and policy, opioid competition from big pharma, and the corruption that overlays this topic, aligning with SXS’s mission to expose corruption and craft epic, truth-telling narratives. The current context is as of 10:36 PM PDT on Tuesday, June 03, 2025.

Background and Context

Kratom, derived from the Mitragyna speciosa tree native to Southeast Asia, is used by nearly 2 million Americans annually for pain relief and addiction management, per the Substance Abuse and Mental Health Services Administration’s 2021 National Survey on Drug Use and Health National Survey on Drug Use and Health. Unlike cannabis, with its broad endocannabinoid system interactions, kratom’s medicinal molecules target pain and addiction, making it a narrow but critical focus. Research suggests its illicit market has less stigma, with federal efforts to ban it largely backed down, unlike cannabis, per the DEA’s 2016 reversal. The project aims to expose hype, bullshit, and criminal activities, aligning with SXS’s goal of rooting out evil and telling the greatest story never told.

Evaluation Process

To identify pertinent information, I reviewed recent data from the FDA, DEA, UNODC, and industry reports, focusing on supply chain dynamics, regulatory actions, health risks, and criminal cases. The process involved analyzing web sources for importing, processing, sales, enforcement, opioid competition, and corruption, ensuring a critical lens on establishment narratives and their gaps.

Pertinent Information by Aspect

Importing the Leaf

• Supply Chain: Kratom is sourced from Southeast Asia, primarily Indonesia, where 250,000 farmers harvest leaves, processed in Pontianak, and shipped to US ports like Oakland and Tampa, per the Tampa Bay Times. The journey exceeds 15,000 miles, with over a third within the US, involving blending and packaging.

• Regulatory Challenges: The FDA’s Import Alert 54-15, updated February 21, 2025, subjects kratom to detention without physical examination (DWPE) due to health risks, per FDA. It seems likely that this strict stance, with reasons like respiratory depression and liver damage, drives smuggling, as seen in Sebastian Guthery’s case, importing 9,800 kg mislabeled as fertilizer, per the Southern District of California.

• Criminal Activities: Research suggests smuggling and mislabeling are prevalent, with cases like Guthery’s involving money laundering, indicating corruption. The evidence leans toward importers exploiting regulatory gaps, with X posts highlighting fears of customs bribery to bypass DWPE.

• Pertinent Information: Investigate smuggling tactics (e.g., mislabeling as potpourri), impact of DWPE on supply, and corruption in customs, focusing on Southeast Asian exporters and US importers.

Processing and Purification

• Process: In Southeast Asia, leaves are dried and ground into powder or extracted, then further processed in the US into capsules, gummies, or liquid shots, per NIDA. The Tampa Bay Times notes O.P.M.S. involves blending and cooking in the US, creating health risks.

• Health Risks: It seems likely that processing inconsistencies lead to contaminated products, with FDA seizures finding Salmonella and heavy metals, per FDA press releases. This suggests criminal negligence in purification.

• Criminal Activities: The evidence leans toward underground labs cutting corners, potentially mixing kratom with synthetic opioids, as seen in overdose cases linked to O.P.M.S., per wrongful death lawsuits.

• Pertinent Information: Examine processing quality control, contamination risks, and underground operations exploiting lax state laws, focusing on US processing facilities and their links to importers.

Products and Sales

• Market Dynamics: Kratom is a billion-dollar industry, sold online, at gas stations, and smoke shops, often with exaggerated claims like pain relief and addiction treatment, per Banner Health. The AKA calls for FDA regulation, citing consumer risk, per Food Safety News.

• Health Risks: Research suggests sales of unsafe products, with nearly 600 fatal overdoses linked to kratom in Florida over a decade, per the Tampa Bay Times, often due to lack of dosage advice, per NBC News.

• Criminal Activities: It seems likely that bad actors market adulterated products, exploiting the lack of oversight, with X posts highlighting gas station kratom as “gas station heroin,” suggesting criminal profiteering.

• Pertinent Information: Investigate marketing hype, product safety, and illegal sales channels, focusing on online platforms, retail outlets, and their ties to importers.

Enforcement and Policy

• Regulatory Landscape: The FDA warns against kratom use, per FDA, but federal regulation is weak, with states varying from bans (e.g., Alabama) to consumer protection acts (e.g., Utah), per Bicycle Health. The DEA’s 2016 reversal of a ban, per U.S. Pharmacist, suggests less stigma than cannabis.

• Enforcement Gaps: It seems likely that enforcement varies, with FDA seizures (e.g., 90,000 bottles in 2024) but limited impact on illicit markets, per FDA press releases. X posts criticize lax state enforcement, suggesting loopholes.

• Criminal Activities: The evidence leans toward regulatory gaps enabling illegal sales, with importers exploiting state differences, as seen in Guthery’s case.

• Pertinent Information: Analyze enforcement effectiveness, state vs. federal policies, and gaps exploited by criminals, focusing on FDA actions and state legislation.

Opioid Competition from Big Pharma

• Market Competition: Kratom competes with prescription opioids for pain and addiction treatment, per NIDA, threatening big pharma’s $50 billion market, per X posts on opioid lobbying. It seems likely that big pharma influences policy to restrict kratom, per Food Safety News.

• Health Claims: Research suggests kratom’s opioid-like effects, with 7-hydroxy mitragynine having 46-fold greater mu-opioid receptor effect than mitragynine, per NIDA, but the FDA lacks approval, per FDA.

• Criminal Activities: The evidence leans toward lobbying corruption, with big pharma potentially bribing officials to maintain market dominance, per X posts on pharmaceutical influence.

• Pertinent Information: Investigate big pharma’s lobbying, FDA’s stance, and impact on kratom regulation, focusing on financial ties and policy influence.

Corruption and Criminal Activities

• Supply Chain Corruption: Corruption overlays kratom’s trade, from bribes to get shipments through customs to money laundering, as in Guthery’s case, per the Southern District of California. The Tampa Bay Times notes O.P.M.S.’s secretive supply chain, suggesting hidden financial dealings.

• Market Exploitation: It seems likely that criminal networks exploit regulatory gaps, with X posts highlighting underground labs mixing kratom with synthetics, per overdose cases.

• Pertinent Information: Examine bribery, money laundering, and underground operations, focusing on importers, distributors, and their ties to law enforcement.

Conclusion

Research suggests kratom’s illicit market has less stigma, with federal efforts to ban it largely backed down, unlike cannabis, per DEA actions. It seems likely that pain and addiction are key, given kratom’s narrow medicinal focus, with the evidence leaning toward corruption in importing, processing, and sales, highlighted by smuggling cases like Guthery’s. SXS’s "State of Kratom" should investigate these areas to expose hype, bullshit, and criminal activities, aligning with their mission to tell the greatest story never told.

Key Citations

• National Survey on Drug Use and Health 2021 Report

• FDA and Kratom Public Health Focus

• The DEA Changes Its Mind on Kratom Article

• Kratom Company and Owner Plead Guilty to Illegal Importation and Money Laundering

• A major US kratom brand relies on a maze of companies

• US Marshals seize dietary supplements containing kratom Press Release

• Kratom is Legal, But Is It Really Safe? Health Blog

• Industry group calls for FDA regulation of Kratom News

• Kratom Use Statistics & Legality By State Health Blog

• Kratom consumed in Southeast Asia versus products consumed in the US NIDA Abstract

• Kratom targeted in crackdowns by states and cities News

- - -